These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35394898)

  • 41. Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age.
    Bravo LC; Carlos JC; Gatchalian SR; Montellano MEB; Tabora CFCB; Thierry-Carstensen B; Tingskov PN; Sørensen C; Wachmann H; Bandyopadhyay AS; Nielsen PI; Kusk MV
    Vaccine; 2020 Jan; 38(3):530-538. PubMed ID: 31703934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observational study.
    Chu K; Li Y; Yu D; Song Y; Liu S; Xue F; Shan Y; Meng W; Pan H
    Vaccine; 2023 May; 41(22):3467-3471. PubMed ID: 37127526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China.
    Li RC; Li CG; Wang HB; Luo HM; Li YP; Wang JF; Ying ZF; Yu WZ; Shu JD; Wen N; Vidor E
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):287-96. PubMed ID: 26407255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses.
    Sun M; Li C; Xu W; Liao G; Li R; Zhou J; Li Y; Cai W; Yan D; Che Y; Ying Z; Wang J; Yang H; Ma Y; Ma L; Ji G; Shi L; Jiang S; Li Q
    Clin Infect Dis; 2017 May; 64(10):1317-1325. PubMed ID: 28419204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba.
    Cuba IPV Study Collaborative Group
    N Engl J Med; 2007 Apr; 356(15):1536-44. PubMed ID: 17429085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China.
    Chen S; Ying Z; Liu Y; Li Y; Yu Y; Huang M; Huang Z; Ou Z; Liao Y; Zhang Y; Liu G; Zhao W; Fu R; Shou Q; Zheng M; Liao X; Tu Y; Stek J; Hartzel J; Li C; Zhang J
    Hum Vaccin Immunother; 2024 Dec; 20(1):2324538. PubMed ID: 38509699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba.
    Resik S; Tejeda A; Mach O; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter R
    Vaccine; 2015 Jan; 33(2):307-13. PubMed ID: 25448109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months.
    Feng G; Jiang D; Han W; Xie Z; Jiang Z; Huang L; Wang J; Zhang W; Xu L; Tan J; You W; Cui G; Li C; Wang Y
    Int J Infect Dis; 2023 May; 130():20-27. PubMed ID: 36682682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis.
    Macklin GR; Grassly NC; Sutter RW; Mach O; Bandyopadhyay AS; Edmunds WJ; O'Reilly KM
    Lancet Infect Dis; 2019 Oct; 19(10):1121-1128. PubMed ID: 31350192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study of immunogenicity after primary vaccination by different sequential program of inactivated poliovirus vaccine and oral poliovirus vaccine].
    Lu L; Li XM; Liu DL; Zhang HR; Zhang ZJ; Wang HH; Liu F; Ning ZQ; Zhang LW; Chu P; Xie YT; Xu Y; Li J; Pang XH; Deng Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):510-3. PubMed ID: 22943896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity study to investigate the interchangeability among three different types of polio vaccine: A cohort study in Japan.
    Ohfuji S; Ito K; Ishibashi M; Shindo S; Takasaki Y; Yokoyama T; Yokoyama T; Yamashita Y; Shibao K; Nakano T; Tsuru T; Irie S; Hirota Y
    Medicine (Baltimore); 2017 Jun; 96(23):e7073. PubMed ID: 28591046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial.
    Liao G; Li R; Li C; Sun M; Li Y; Chu J; Jiang S; Li Q
    J Infect Dis; 2012 Jan; 205(2):237-43. PubMed ID: 22158682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity of enhanced potency inactivated polio vaccine.
    Singh J; Ravi RN; Dutta AK; Kumari S; Khare S
    Indian Pediatr; 1992 Nov; 29(11):1353-6. PubMed ID: 1338200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.
    Saleem AF; Mach O; Quadri F; Khan A; Bhatti Z; Rehman NU; Zaidi S; Weldon WC; Oberste SM; Salama M; Sutter RW; Zaidi AK
    Vaccine; 2015 Jun; 33(24):2757-63. PubMed ID: 25917673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study.
    Capeding MR; Gomez-Go GD; Oberdorfer P; Borja-Tabora C; Bravo L; Carlos J; Tangsathapornpong A; Uppala R; Laoprasopwattana K; Yang Y; Han S; Wittawatmongkol O
    J Infect Dis; 2022 Aug; 226(2):308-318. PubMed ID: 33351072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine.
    Tang R; Li G; Zhang C; Zhi H; Zhu J; Wang J; Liang Q; Hu Y; Li C
    Hum Vaccin Immunother; 2020 Nov; 16(11):2641-2648. PubMed ID: 32347778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis.
    Mashunye TR; Ndwandwe DE; Dube KR; Shey M; Shelton M; Wiysonge CS
    Lancet Infect Dis; 2021 Aug; 21(8):1161-1174. PubMed ID: 33939958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.
    Qiu J; Yang Y; Huang L; Wang L; Jiang Z; Gong J; Wang W; Wang H; Guo S; Li C; Wei S; Mo Z; Xia J
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28362135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.